⌘K

Login Start Free

Home/Filings/4/0001628280-22-025857

4//SEC Filing

KAPLAN GILLA 4

Accession 0001628280-22-025857

CIK 0001534120other

View on SEC.gov Company Profile

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:25 PM ET

Size

5.4 KB

Accession

0001628280-22-025857

Insider Transaction Report

Form 4

Period: 2022-09-30

Avalo Therapeutics, Inc.AVTX

Director

Transactions

Award
Stock Option (Right to Buy)
2022-09-30+3,080→ 3,080 total
Exercise: $3.32From: 2022-09-30Exp: 2032-09-30→ Common Stock (3,080 underlying)

Footnotes (1)

[F1]100% of the stock option will immediately vest on the date that it is granted.

Documents

1 file

4
wf-form4_166482872994312.xmlPrimary
FORM 4

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1

filerCIK 0001247024

Filing Metadata

Form type: 4
Filed: Oct 2, 8:00 PM ET
Accepted: Oct 3, 4:25 PM ET
Size: 5.4 KB

View on SEC.gov